Attributable Risk And Specific Causation

Law360, New York (November 10, 2008, 12:00 AM EST) -- The plaintiff in a pharmaceutical products liability or toxic tort case must prove by a preponderance of the evidence that the drug or other substance more likely than not caused or contributed to his alleged injury.

Proving causation in such cases typically involves a two-step process: the plaintiff first must prove that the substance is capable of causing the type of harm alleged (i.e., general causation) and then must prove that his particular exposure to it in fact caused his alleged injury (i.e., specific causation)....
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.